UNSPSC 51422308: Dichlorisone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H26CL2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, AMW2MRV3OT chemically known as 9.alpha.,11.beta.-dichloro-17.alpha.,21-dihydroxypregna-1,4-diene-3,20-dione but generally known as dichlorisone, which bears US NIH Compound Identifier 23441. European Medicines Agency schedules Dichlorisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07083MIG.

UNSPSC 51422308 Dichlorisone is a Commodity code that in recent state and local procurement reflects solicitation of naloxone, drug deactivation systems, and related pharmaceutical products and services supporting community health and pharmacy benefit programs. The code spans purchases by county health departments and state health and human services agencies seeking to procure pharmaceutical products, drug-disposal systems, and pharmacy program infrastructure. Recent opportunities show county governments and state health agencies using the code to source naloxone units and safe drug deactivation systems for public health initiatives, as well as to explore direct-to-manufacturer pharmacy contracting models that bypass traditional pharmacy benefit manager and wholesaler channels.

Seminole County, Florida posted an IFB (Solicitation IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford; the bid response deadline was July 26, 2023, and the contract carried a two-year initial term with a one-year renewal option. The Texas Health and Human Services Commission issued an RFI (HHS0017013) posted April 3, 2026, to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program seeking direct contracting relationships between the state and manufacturers to improve prescription fulfillment and cost management. Recent activity is concentrated in Florida and Texas, with issuing bodies spanning county health departments and state human services commissions.